BLFS
NASDAQBioLife Solutions Inc.
SectorHealth CareIndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
News · 26 weeks65+383%
2026-04-192026-10-11
Mix4690d
- Insider20(43%)
- SEC Filings18(39%)
- Other4(9%)
- Earnings2(4%)
- Analyst1(2%)
- Leadership1(2%)
Latest news
25 items- SECSEC Form 15-12G filed by BioLife Solutions Inc.15-12G - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- SECSEC Form EFFECT filed by BioLife Solutions Inc.EFFECT - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- SECSEC Form EFFECT filed by BioLife Solutions Inc.EFFECT - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by BioLife Solutions Inc.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- SECSEC Form S-8 POS filed by BioLife Solutions Inc.S-8 POS - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- SECSEC Form S-8 POS filed by BioLife Solutions Inc.S-8 POS - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- SECSEC Form S-8 POS filed by BioLife Solutions Inc.S-8 POS - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- SECSEC Form POS AM filed by BioLife Solutions Inc.POS AM - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- SECSEC Form POS AM filed by BioLife Solutions Inc.POS AM - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- SECSEC Form 8-K filed by BioLife Solutions Inc.8-K - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- PRRepligen Completes Acquisition of BioLife SolutionsWALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN, "Repligen", or the "Company")), a life sciences company focused on bioprocessing technology leadership, today announced it has completed the previously announced acquisition of BioLife Solutions, Inc. (NASDAQ:BLFS, "BioLife")), a leading developer and supplier of cell processing tools and services for the cell and gene therapy market. "We are excited to welcome BioLife team members to Repligen," said Olivier Loeillot, President and Chief Executive Officer of Repligen. "BioLife’s highly-differentiated portfolio of products expands our presence in the rapidly growing cell therapy market, adding a deeply emb
- PRFreshworks Set to Join S&P SmallCap 600NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Freshworks Inc. (NASD: FRSH) will replace BioLife Solutions Inc. (NASD:BLFS) in the S&P SmallCap 600 effective prior to the open of trading on Thursday, October 8. S&P MidCap 400 constituent Repligen Corp. (NASD:RGEN) is acquiring BioLife Solutions in a deal expected to be completed soon, pending final closing conditions.Following is a summary of the change that will take place prior to the open of trading on the effective date:Effective Date Index NameCompany Name Ticker GICS Sector October 8, 2026S&P SmallCap 600Addition FreshworksFRSH Information Technology October 8, 2026S&P SmallCap 600 Deletion BioLife SolutionsBLFSHealth CareABOUT S&P DOW JONES I
- SECSEC Form DEFA14A filed by BioLife Solutions Inc.DEFA14A - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- SECSEC Form 425 filed by BioLife Solutions Inc.425 - BIOLIFE SOLUTIONS INC (0000834365) (Subject)
- INSIDERChief Marketing Officer Berard Todd covered exercise/tax liability with 470 shares, decreasing direct ownership by 0.29% to 161,823 units (SEC Form 4) to satisfy withholding tax4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
BLFS FAQ
6 questionsWhat does BioLife Solutions Inc. do?
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing...Where does BLFS stock trade?
BioLife Solutions Inc. (BLFS) is listed on NASDAQ.What sector and industry is BLFS in?
BioLife Solutions Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.What are analysts saying about BLFS?
BioLife Solutions Inc. has had 8 recent analyst actions on file. The most recent action was from The Benchmark Company: Hold on 2026-08-10. Recent price targets range from $2200.00 to $3000.00.What companies are similar to BLFS?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare BLFS side-by-side with any of them on Quantisnow.How can I track BLFS on Quantisnow?
Quantisnow aggregates BioLife Solutions Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BLFS to receive live email and push alerts on every new disclosure.